Key result
LPA variants linked to ~47% higher PAD risk, but not venous thromboembolism.
Why the study?
It is unclear whether LPA variants rs10455872 and rs3798220 confer susceptibility to vascular diseases predominantly via atherosclerosis or thrombosis.
Are LPA genetic variants associated with atherosclerotic and thrombotic vascular diseases?
Observational
Are LPA genetic variants associated with atherosclerotic and thrombotic vascular diseases?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The main conclusion to draw from this work is that Lp(a) is probably a strong causal factor in not only CAD, but also the development of atherosclerosis in other arterial trees. Although there is no evidence from this study that Lp(a) levels contribute to venous thrombosis, the investigators do not exclude a role for Lp(a) in arterial thrombosis.”
LPA genetic risk variants are strongly associated with systemic atherosclerotic burden across multiple vascular beds, but not with primarily thrombotic phenotypes like venous thromboembolism.
OBJECTIVES: The purpose of this study is investigate the effects of variants in the apolipoprotein(a) gene (LPA) on vascular diseases with different atherosclerotic and thrombotic components. BACKGROUND: It is unclear whether the LPA variants rs10455872 and rs3798220, which correlate with lipoprotein(a) levels and coronary artery disease (CAD), confer susceptibility predominantly via atherosclerosis or thrombosis. METHODS: The 2 LPA variants were combined and examined as LPA scores for the association with ischemic stroke (and TOAST [Trial of Org 10172 in Acute Stroke Treatment] subtypes) (effective sample size [n(e)] = 9,396); peripheral arterial disease (n(e) = 5,215); abdominal aortic aneurysm (n(e) = 4,572); venous thromboembolism (n(e) = 4,607); intracranial aneurysm (n(e) = 1,328); CAD (n(e) = 12,716), carotid intima-media thickness (n = 3,714), and angiographic CAD severity (n = 5,588). RESULTS: LPA score was associated with ischemic stroke subtype large artery atherosclerosis (odds ratio [OR]: 1.27; p = 6.7 × 10(-4)), peripheral artery disease (OR: 1.47; p = 2.9 × 10(-14)), and abdominal aortic aneurysm (OR: 1.23; p = 6.0 × 10(-5)), but not with the ischemic stroke subtypes cardioembolism (OR: 1.03; p = 0.69) or small vessel disease (OR: 1.06; p = 0.52). Although the LPA variants were not associated with carotid intima-media thickness, they were associated with the number of obstructed coronary vessels (p = 4.8 × 10(-12)). Furthermore, CAD cases carrying LPA risk variants had increased susceptibility to atherosclerotic manifestations outside of the coronary tree (OR: 1.26; p = 0.0010) and had earlier onset of CAD (-1.58 years/allele; p = 8.2 × 10(-8)) than CAD cases not carrying the risk variants. There was no association of LPA score with venous thromboembolism (OR: 0.97; p = 0.63) or intracranial aneurysm (OR: 0.85; p = 0.15). CONCLUSIONS: LPA sequence variants were associated with atherosclerotic burden, but not with primarily thrombotic phenotypes.
No takes yet. Share an insight, caveat, or question.
Helgadóttir et al. (2012) conducted an observational in Systemic Atherosclerosis and Coronary Atherosclerotic Burden. LPA genetic sequence variants (rs10455872 and rs3798220) vs. Non-carriers or lower LPA score was evaluated on Peripheral artery disease (OR 1.47, p=2.9 × 10(-14)). LPA sequence variants were associated with peripheral artery disease and other atherosclerotic burdens, but not with venous thromboembolism.
Synapse has enriched 10 related papers. Consider them for comparative context: